The composition of gut bacteria appears to be associated with how much latent HIV remains in the blood of people receiving antiretroviral therapy. This is shown in a new study from Karolinska Institutet, published in Gut Pathogens. The findings offer clues as to how the gut microbiome may influence the amount of virus that persists in the body.